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Clostridium perfringens, a Gram-positive anaerobic bacterium, is
widespread in the environment and commonly found in the intestines
of animals, including humans. C. perfringens strains are classified
into five toxinotypes (A, B, C, D and E) based on the production of
four major toxins (α, β, ε, ι). However the toxins (theta, delta,
lambda and enterotoxin) are also synthesized by C. perfringens
strain. Many attempts to purify the toxins produced by C.
perfringens have been proposed. In this review we discuss the
purification methods used to isolate toxins from C. perfringens
reported in last four decades.
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INTRODUCTION
Recent advances in genetic engineering, DNA
recombinant technology, cellular fusion technology, and
biotechnology in general, make possible the commercial
production of new active products as pharmaceuticals,
vaccines and hormones. However, the general purification
technology for these products has been developed slowly
mainly as compared to the production technology.
Purification is troublesome because of system complexity
and the need to retain biological activity. Usually, biological
material has been purified by precipitation with salts or
organic solvents, and by using various chromatographic
techniques, all of them having enormous difficulties in
large-scale applications (Alves et al., 2000). Besides,
according to Diamond and Hsu (1992), 50-90% of the
biological products production costs are determined by the
purification strategy.
Many attempts to purify toxins from Clostridium
perfringens have been reported (Krug, Kent, 1984;
Moreau, Jolivet-Reynaud, Alouf, 1986; Stephen, 1961;
Ito, 1968; Smyth, Arbuthnott., 1974; Mitsui, Mitsui, Hase,
1973; Möllby, Wadström, 1973; Bird, Low, Stephen,
1974; Takahashi, Sugahara, Ohsaka, 1974; Yamakawa,
Ohsaka, 1977; Jolivet-Reynaud, Moreau, Alouf, 1988)
However the separation is rather difficult since the variety
of toxins produced from this microorganism is high (12
toxins are known) (Hirata et al. 1995). Generally, the main
methods used for protein purification are carried out by
chromatography as ion exchange, affinity, hydrophobic
interaction, and gel filtration. These different types of pro-
cesses provide the choice for selective fractionation and
concentration of macromolecular commodities and the
new expanding portfolio of bioproducts (Lyddiatt, 2002).
C. perfringens is a Gram-positive anaerobic
bacterium, and able to form spores. It is widespread in the
environment, commonly found in the intestines of animals
and humans, and can be pathogenic. In humans, it can
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cause gangrene and gastrointestinal diseases (for instance:
food poisoning and necrotic enteritis), whereas in other
animals, gastrointestinal and enterotoxemic diseases
occur more frequently (Petit, Gibert, Popoff, 1999;
Gkiourtzidis et al., 2001).
C. perfringens strains are classified into five
toxinotypes (A, B, C, D and E) based on the production of
four major toxins (α, β, ε, ι) (Table I) (Petit, Gibert,
Popoff, 1999). C. perfringens type A is the most common
toxinotype in the environment, is ubiquitous, and
responsible for gangrene in humans, mediated primarily
by α-toxin, secondarily by θ-toxin and hydrolytic
enzymes. This strain is also associated with food
poisoning in humans, because synthesizes an enterotoxin
(CPE) that is responsible for the gastrointestinal
symptoms. Unlike other toxins, CPE is only produced
during sporulation (McClane, 1996). The enterotoxin
(CPE) is also produced by toxinotype B, C, D and E (Table
II) (McClane, 1996). C. perfringens types B produce α-
toxin, β-toxin and ε-toxin, but the higher production is β-
toxin, which causes enterotoxemia and necrotic enteritis
in lambs, piglets and calves (Table I). In humans, the β-
toxin is a known cause of necrotic enteritis
(Steinthorsdottir et al.,1995). C. perfringens types C
produce α-toxin and β-toxin (Table I). C. perfringens
type D produces α-toxin and ε-toxin, however its higher
production is of ε-toxin (Table I). The C. perfringens type
E produces ι-toxin, which has been implicated in fatal calf,
lamb, and guinea pig enterotoxemia (Table I) (Bosworth,
1943; Madden, Horton, McCullough, 1970). C.
perfringens type B, E and some by type D, produce λ-
toxin, which cause enteritis and enterotoxemia in domestic
animals (Table II) (Bidwell, 1950; Hatheway, 1990; Rood,
Cole, 1991). This λ-toxin may contribute to the
pathogenesis by activating other potent toxins, such as the
ε- and ι-toxins produced by these type strains (Jin et al.,
1996).
C. perfringens type C and some by type B, produce
δ-toxin, which is one of the three extracellular hemolytic
toxins that can be released, along with many other
exotoxins and exoenzymes (Brooks, Stern, Warrack,
1957; Glenny et al., 1933; Oakley, Warrack, 1953; Orlans,
Jones, 1958; Smith, 1979; Sterne, Warrack, 1964).
In this review, the purification methods of toxins,
produced by C. perfrigens, are presented and discussed.
The information here presented can help the production of
antigens aiming industrial application, and the
comprehension of their structures or effects.
Alpha-toxin (α)
Alpha toxin is one of the most important lethal and
dermonecrotic toxins produced by C. perfringens, known
as phospholipase C (PLC). It is produced in different
amounts by all types (A, B, C, D, E) of C. perfringens and
is considered as a primary virulence factor involved in
clostridial myonecrosis (Williamson, Titball, 1993; Award
et al., 1995). In C. perfringens type A, the alpha-toxin is
TABLE I – Diversity of Clostridium perfringens toxinotypes and associated diseases (Petit, Gibert, Popoff, 1999)
Toxinotype Major Toxins Minor Toxins Associated diseases
α β ε ι CPE λ θ δ Humans Animals
A ++ – – – + – + – Gangrene Diarrhea (foals, pigs…)
Gastrointestinal Necrotic enteritis in fowl
diseases
B + + + – + + – + – Dysentery in newborn lambs
Hemorragic enteritis in
neonatal calves and foals
Enterotoxemia in sheep
C + + – – + – – + Necrotic enteritis Necrotic enteritis in piglets,
lambs, calves and foals
Enterotoxemia in sheep
D + – + – + + – – – Enterotoxemia in lambs,
sheep, calves and goats
E + – – + + + – – – Enterotoxemia in calves
– – no detected toxin production; + – detected toxin production; ++ – highest toxin producer
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the unique lethal protein produced during vegetative
growth. Owing to its role in gas gangrene disease, food
poisoning and animal enterotoxemia, C. perfringens type
A strains, particularly the alpha-toxin, have been the
subject of intense investigations over the past 60 years
(McDonel, 1986). Alpha-toxin, produced by C.
perfringens, is a metalloenzyme with molecular weight of
43 kDa (Takahashi, Sugahara, Ohsaka, 1974; Hale, Stiles,
1999) and LD50 of 40 ng/mL
-1 (Naylor, Martin, Barker,
1997), and catalyses the hydrolysis of lecithin and
phospholipids (Saint-Joanis, Garnier, Cole, 1989; Hale,
Stiles, 1999).
C. perfringens produces many different biologically
active proteins, thus complicating the characterization of
any one specific toxin without laborious purification
procedures (Macchia, Bates, Pastan, 1967). Various
methods of purification have been proposed for alpha-
toxin (Mitsui, Mitsui, Hase, 1973a; Bangham, Dawson,
1962; Macchia, Bates, Pastan, 1967; Shemanova et al., 1968;
Diner, 1970; Sugahara, Ohsaka, 1970; Ispolatovskaya,
1971; Casu et al., 1971; Stahl, 1973). They include
conventional or classical procedures such as precipitation
with salts or organic solvents, electrophoresis, gel filtra-
tion, and adsorption or ion exchange chromatography. The
first purification of alpha-toxin was achieved by precipi-
tation with mixture sodium sulfate and ammonium sulfate
(MacFarlane, Knight, 1941), and subsequently by precipi-
tation with ammonium sulfate (Saint-Joanis, Garnier,
Cole, 1989). The crude toxin was precipitated with
different concentrations of ammonium sulfate, until to
TABLE II – Mode of action and biological activity of Clostridium perfringens toxins
Toxin Mode of action Homology9 Biological activity
α Phospholipase C / α toxin C. novyi (60.8%) Cytolytic, hemolytic,
sphingomyelinase α toxin C. bifermentans (50.8%) dermonecrotic, lethal1
phospolipase C Bacillus cereus
(26.5%)
β1, β2 Pore-forming activity γ-hemolysin (30%) Cytolytic, dermonecrotic, lethal
Cell membrane α toxin (27.4%) hemorragic necrosis of intestinal
disruption? leukocidin components mucosa2
D, E, F (21.1-29.6%)
ε Alteration of cell Mtx3, Bacillus sphaericus (26.7%) Edema in various organs: liver,
membrane permeability C53, B. thuringiensis (26.5%) kidney and central nervous system,
Mtx2, Bacillus sphaericus (20.2%) dermonecrotic, lethal3
ιa, ιb ADP-ribosylation of C. spiroforme toxin (78.6-80.7%) Disruption of actin cytoskeleton,
actin for Ia CDT C. difficile (80.4-80%) disruption of cell barrier integrity
C2 C. botulinum (31.1-40%) dermonecrotic, lethal4
δ Hemolysin, specific Additional virulence factors5
GM2
λ Protease Protease, B. thuringiensis(43.2%) Additional virulence factors6
Protease, Lactobacillus sp. (42.5%)
θ Hemolysin, specific Alveolisin, B. alvei (71.4%) Additional virulence factors7
to cholesterol Hemolisin, B. cereus (66.9%)
Streptolisin O, Streptococcus
pyogenes (63.5%)
 (CPE) Pore-forming activity C. botulinum C ( 24%) Cytotoxic, erythematous, lethal leakage
of water and ions by enterocytes,
diarrhea8
1-Buting et al., 1997; Saint-Joanis, Garnier, Cole, 1989.; 2-Gibert, Jolivet-Reynaud, Popoff, 1997; Hunter et al. 1993;
Sakurai, Fujii, 1987; 3-Petit, Gibert, Popoff, 1997; Hunter et al., 1992; 4-Perelle et al., 1993; Perelle et al., 1995;
Vandekerckhove et al., 1987; 5-Alouf, Jolivet-Reynaud, 1981; 6-Jin et al., 1996; 7-Tweten, 1988; 8-Williamson, Titball,
1993; Award et al., 1995; 9-Petit, Gibert, Popoff, 1999.
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achieve the desired degree of ammonium sulfate
saturation. After, one the table was elaborated to determi-
ne the exact concentrations of ammonium sulfate
(McDonel, 1980; Saint-Joanis, Garnier, Cole, 1989).
The ammonium sulfate precipitation was often used to
prepare a crude toxin for application to gel filtration
chromatography (Ito, 1968; Mitsui, Mitsui, Hase, 1973a;
Diner, 1970; Ikezawa, Yamamoto, Murata, 1964;
Katsaras, Hartwigk, 1979) or electrofocusing (Smyth,
Arbuthnott, 1974). These purification steps provided poor
recovery yields, such as 54% (van Heyningen, 1941), 56%
(Bangham, Dawson, 1962), 14% (Roth, Pillemer, 1953),
and 56.6% (Smyth, Arbuthnott, 1974) (Table III). During
the ammonium sulfate precipitation, the alpha-toxin
suffers considerable biochemical modifications, with
possible denaturation of the molecular structure
(Odendaal, 1987).
Stephen (1961) was one of the first author to employ
high-pressure ultrafiltration to obtain alpha-toxin in high
concentration, and the method used to purify was zone
electrophoresis and immunoelectrophoresis (Method 1)
(Table III). The efficiency of high-pressure ultrafiltration for
purification of alpha-toxin was evaluated by Odendaal
(1987), and its use was compared in 4 different purification
methods (Table III). The results obtained with 3 different
ultrafiltration membranes followed by gel filtration showed
that by using the membranes Millipore™ PSED OHV10 and
Amicon™ XM-100 filter (method 7), a three-hundred-and-
fivefold purification could be achieved as against a twelve-
fold increase obtained with ammonium sulphate/acetone
precipitation (method 5). The ultrafiltration process is less
time-consuming, easier to perform and less laborious than
ammonium sulfate and acetone precipitations. Method 5 was
easy and relative fast, but showed low purification factor
(12.7-fold); method 6 showed to be easy to perform, less
laborious, less time-consuming, provided high purification
factor (200-fold), but was of high cost. Method 8 showed to
be easy to perform, less laborious, less time-consuming, but
showed low purification factor (24-fold) (Table III).
Alpha-toxin has been successfully purified through
chromatography column, specifically ion exchange. It was
purified by the method 2, in batchwise, and reached a 200-
fold increase in specific activity (Möllby, Wadström,
1973) (Table III). Yamakawa and Ohsaka (1977) purified
alpha toxin by using method 4; the final product was
purified in approximately 15.5-fold, and 17% the toxin
was recovered (Table III). In comparison with the others
methods described, this method was inefficient of the
point of view of purification factor and recovery.
C. perfringens alpha-toxin was also purified by
affinity chromatography described for method 3 (Table III).
The purification factor encountered was 200-fold, with a
recovery yield of about 60% of enzymatic, lethal or
hemolytic activity. The purified toxin was homogenous in
polyacrylamide gel electrophoresis, ultra-centrifugation
and immunodiffusion. By isoelectric focusing of the
purified toxin, three major molecular forms were encoun-
tered (Takahashi, Sugahara, Ohsaka, 1974) (Table III).
The alpha-toxin from recombinant Bacillus subtilis
cells was purified after three steps: ammonium sulfate
precipitation (60% saturation), which was followed by
affinity chromatography (Sepharose 4B-linked egg yolk
lipoprotein column), and then by chelating chromato-
graphy (Sepharose Fast Flow gel column). The three
purification steps yielded increasingly pure toxin. The fi-
nal step resulted in a homogeneous product that was
purified approximately 130-fold, and 23% of the toxin
was recovered (Hirata et al.,1995).
Comparing all described aforementioned methods,
it can be observed that the use of chromatography methods
(size exclusion molecular, affinity chromatography, ion
exchange) is very important to obtain pure toxins. The
combined utilization of size exclusion chromatography
and utlrafiltration membranes provided higher purifica-
tion factor, but this procedure its of high cost.
Beta-toxin (β)
Beta-toxin is produced only by C. perfringens types
B and C (Table I), and causes enterotoxemia and necrotic
enteritis in lambs, piglets and calves. In humans, this toxin
causes necrotic enteritis. In spite of the importance of beta-
toxin in veterinary medicine, the biological activity of this
protein is poorly defined (Steinthorsdottir et al., 1995;
Gkiourtzidis et al., 2001). Its molecular weight is 35 kDa
(Hsieh et al., 1998), LD50 is 310 ng/kg-1 (Jin et al., 1996).
According to Hauschild (1971) the combined effects
of beta- and epsilon-toxins are responsible for the diseases
caused by C. perfringens type B, such as lamb dysentery
and enterotoxemia of foals, goats, sheep and calves.
Beta-toxin is responsible for the diseases caused by
C. perfringens type C which including Struck of sheep and
enterotoxemia of lambs, calves and piglets and necrotic
enteritis of man and fowls (Hauschild, 1971). Most of the
conditions in which beta-toxin plays the major role are
characterized by ulceration of the intestines or acute
hemorrhage enteritis (Worthington, Mülders, 1975). The
purification of this toxin is necessary to study the
mechanism of action.
The beta-toxin was purified after four steps (method
1), as presented in Table IV, and the final purification
factor was of 28-fold (Worthington, Mülders, 1975). The
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2nd purification method of beta-toxin involved
immunoaffinity chromatography (Table IV). The toxin
was purified about 340-fold from the culture supernatant
of C. perfringens type C with a yield of about 24%, in
terms of biologically active beta-toxin. Purity of the toxin
was checked by polyacrylamide gel electrophoresis; a
purified toxin gave a single band (Sakurai, Duncan, 1977).
The comparison between the aforementioned
methods indicates that immunoaffinity chromatography to
purify beta-toxin should be utilized, since the purification
factor was of 340-fold and the yield of 24%.
Epsilon-toxin (ε)
Epsilon-toxin produced by C. perfringens type B
and D is the third most potent clostridial toxin, after
botulinum and tetanus toxins. This toxin is produced as a
relatively inactive prototoxin with molecular weight of
TABLE III – Purification methods used for a-toxin of C. perfringens
Method  Procedure Purification  Advantages  Disadvantages Ref.
factor (-fold)
1 High pressure – Good purity Not for 1
ultrafiltration, large-scale
electrophoresis and purification
immunoelectrophoresis
2 DEAE-Sephadex A25, 200 Good purity Long time- 2
Sephadex G75 and consuming
isoeletric focusing particularly
for large-scale
purification
3 Affinity chromatography, 200 Good purity Long time- 3
sephadex G100, isoelectric consuming
focusing particularly
for large-scale
purification
4 Ultrafiltration, calcium 15.5 Not for 4
acetate precipitation, large-scale
CM-Sephadex, purification,
DEAE-Sephadex, laborious
sephadex G-100
5 Ammonium sulfate/ 12.7 Easy, and Low purification 5
acetone precipitation, relatively fast factor
gel filtration
6 Ultrafiltration with 200 Easy to perform, High cost 5
Amicon XM-50, less laborious,
gel filtration and less time-
consuming
7 Ultrafiltration with 305 Easy to perform, High cost 5
Millipore PSED OHV 10 less laborious,
and Amicon XM-100, less time-
gel filtration consuming
8 Ultrafiltration XM-100, 24 Easy to perform, Low purification 5
gel filtration less laborious, factor
and less time-
consuming
1-Stephen, 1961; 2-Möllby, Wadström, 1973; 3-Takahashi, Sugahara, Ohsaka, 1974; 4-Yamakawa, Ohsaka, 1977;
5-Odendaal, 1987.
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~33 kDa (Payne, Oyston, 1997; Subramanyam et al.,
2001; Parreiras et al., 2002), and as an active toxin with
molecular weight of 32 kDa (Payne, Oyston, 1997) their
LD50 is 70 ng/kg
-1 (Miyamoto et al., 2000). It is responsible
for the pathogenesis of fatal enterotoxemia in domestic
animals. This toxin exhibits toxicity toward neuronal cells
via the glutamatergic system (Miyamoto et al., 1998;
Miyamoto et al., 2000) or extravasation in the brain
(Finnie, Blumbergs, Manauis, 1999). It has been
suggested that is a pore-forming toxin based on the
following observations: (i) ε-toxin can form a large
complex in the membrane of Madin-Darby canine kidney
cells, and permeabilizes them (Petit et al .  1997;
Nagahama, Ochi, Sakurai, 1998); (ii) the large complex
formed by ε-toxin is not dissociated by SDS-treatment,
which is a common feature of pore-forming toxins (Petit
et al. 1997); and (iii) the CD spectrum of ε-toxin shows
that it mainly consists of β-sheets (Habeeb, Lee, Atassi,
1973), as observed for pore-forming β-barrel toxins. A
characteristic feature of ε-toxin is its potent neurotoxicity,
which is not observed for other structurally well-defined
pore-forming toxins (Miyata et al., 2001). Another
characteristic of ε-toxin is the activation of the inactive
precursor (ε-protoxin) by proteases such as trypsin,
chymotrypsin (Hunter et al., 1992), and λ-protease
produced by C. perfringens .  This activation is
accompanied by removal of both N- and C-terminal
peptides (Jin, et al. 1996; Minami et al., 1997).
Epsilon-protoxin has been purified by methanol
precipitation (Verwoerd, 1960), and by ion exchange
chromatography (Thomson, 1963; Orlans, Richards,
Jones, 1960; Hauschild, 1965; Habeeb, 1969). Protoxin
prepared by Habeeb (1969) presented higher toxicity than
protoxin prepared by other workers above but was not
electrophoretically homogeneous.
Highly purified C. perfringens type D epsilon-
protoxin was prepared from culture filtrate of C.
perfringens by ammonium sulfate precipitation and ion
exchange chromatography (DEAE-cellulose). The
purification factor was approximately 77-fold
(Worthington, Mülders, Van Rensburg, 1973).
Theta-Toxin (θ)
Theta(θ)-toxin is one of the toxins produced by
Clostridium perfringens type A, a causative pathogen for
gas gangrene (Ispolatovskaya, 1971). The toxin is
cytolytic (hemolytic) and lethal, belonging to a group of
oxygen-labile or SH-dependent hemolysin (Bernheimer,
1974; Bernheimer, 1976). In the same group are found
streptolysin O, cereolysin, tetanolysin and listeriolysin
produced by Streptococcus pyogenes, Bacillus cereus,
Clostridium tetani  and Listeria monocytogenes ,
respectively. These hemolysins share common properties
(Bernheimer, 1974; Bernheimer, 1976).
Many workers have attempted to purify theta-toxin
from culture filtrate of Clostridium perfringens but have
failed to obtain the toxin in good yield because of its
instability (Roth, Pillemer, 1955; Mitsui, Mitsui, Hase,
1973b; Smyth, 1975; Soda, Ito, Yamamoto, 1976),
probably because this toxin is formed by isoforms (Smith,
1975) and due the presence of reduced form and oxidized
form toxins (Yamakawa, Ito, Sato, 1977).
The theta-toxin of C. perfringens was purified by a
series of methanol precipitation and subsequent high-speed
centrifugation. The purified preparation was free of kappa
(κ)-toxin and hyaluronidase but contained traces of alpha(α)-
toxin. Electrophoretic patterns indicated that the (θ)-toxin
constituted about 80–90% of the total protein of purified
preparation (Roth, Pillemer, 1955). Authors as Habermann,
TABLE IV - Purification methods used for β-toxin from C. perfringens
Method  Procedure Purification factor (-fold)  Disadvantages
1* ammonium sulfate precipitation, 28 Multiple steps, long
gel filtration chromatography time-consuming
(Sephadex G50, Sephadex G100)
and ion exchange chromatography
(DEAE cellulose).
2** ammonium sulfate fractionation, gel 340 Multiple steps, not for
filtration (Sephadex G-100), large-scale purification
isoelectrofocusing in a pH 3 to 6 gradient,
and immunoaffinity chromatography
*Worthington, Mülders, 1975; **Sakurai, Duncan, 1977
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1959 and Habermann, 1960, purified theta-toxin by methanol
precipitation, starch-gel electrophoresis, and ion exchange
chromatography (DEAE-cellulose). The purified prepa-
rations were free of alpha and kappa-toxins, and hyaluro-
nidase. This purified preparation produced a single spot and
single precipitin line in membrane electrophoresis and in
immunoelectrophoresis, respectively.
By purification method using ammonium sulfate
precipitation and electrofocusing (method 1 – Table V),
four isoforms of theta-toxin were found. The overall
recovery was 86.8% and the purification factor varied,
depending of isoform, of 1060 to 1800-fold (Smyth,
1975).
This toxin was purified by Hauschild, Lecroisey,
Alouf, (1973) by ammonium sulfate precipitation and
successive chromatography steps, described method 2
(Table V). The total recovered theta-toxin was about 20%
of the crude extract. The toxin losses, during the four
purification steps were about 30, 20, 25, and 5%,
respectively. This purification method was developed to
produce pure theta-toxin on large scale. The authors did
not relate purification factor, but tests realized indicated
that the toxin is pure.
Yamakawa, Ito, Sato, (1977) purified theta-toxin
3300 fold from culture filtrate of culture C. perfringens by
initial ion exchange chromatography (DEAE-Sephadex
A-50), and gel filtration chromatography (Sephadex G-
150) (method 3 – Table V). The specific activity was of
105,000 U/mg, with recovery of 50.4%. The
electrophoresis of the solution containing the purified
toxin showed two distinct bands, and indicated the
presence of two forms of toxin.
Iota-Toxin (ι)
The iota-toxin is produced only by C. perfringens
type E and has been implicated in fatal calf, lamb and
guinea pig enterotoxemias (Bosworth, 1943; Madden,
Horton, McCullough, 1970). Its biological activity is
dermonecrotic and lethal. Studies suggested that iota-
toxin is a binary toxin dependent on two non-linked
proteins. The molecular weight of iota-toxin is 47.5 kDa
and of iota b is 71.5 kDa (Stiles, Wilkins, 1986).
The iota-toxin was purified by ammonium sulfate
precipitation followed by ionic exchange chromatography
(DEAE-Sepharose CL-6B), isoeletric focusing, and gel
filtration chromatography (Sephadex G-100). In the first
chromatography, the recoveries were of 88 and 74% for
Iotaa e Iotab , respectively (Stiles, Wilkins, 1986).
Delta-toxin (δ)
C. perfringens delta-toxin is one of the three
extracellular hemolytic toxins released by a number of
type C strains and also possibly by type B strains (Brooks,
Stern, Warrack, 1957; Glenny et al., 1933; Oakley,
Warrack, 1953; Orlans, Jones, 1958; Smith, 1979; Sterne,
Warrack, 1964). The molecular weight of delta-toxin is 42
TABLE V - Purification methods used for θ-toxin of C. perfringens
Method  Procedure Purification  Recovery  Advantages Ref.
factor (-fold)
1 Ammonium sulfate 1060 to 1800 86.8% High purification factor 1
precipitation and and recovery
electrofocusing
2 Ammonium sulfate - 20% Large-scale 2
precipitation, successive purification
chromatography:
DEAE-cellulose,
Sephadex G-100
QAE-Sephadex
3 Anionic exchanger 3300 50.4% High purification factor, 3
chromatography easy to perform
(DEAE-Sephadex A-50),
gel filtration chromatography
(Sephadex G-150)
1- Smyth, 1975; 2- Hauschild, Lecroisey, Alouf, 1973; 3- Yamakawa, Ito, Sato, 1977
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KDa (Alouf, Jolivet-Reynaud, 1981). Previous
investigations established that this toxin was
immunogenic and lytic for the erythrocytes of even-toed
ungulates (sheep, cattle, goats and swine) but not for the
erythrocytes of other species such as humans, rabbits and
horses (Brooks, Stern, Warrack, 1957; Oakley, Warrack,
1953; Willis, 1970). This difference can be owing to the
low sensitivity or number of the specific receptors
(possibly GM2 ganglioside). Besides, the receptors can be
hidden, as suggested by experiments performed with
binded radiolabeled toxin onto cells. The cells might also
differ in their relative distributions around the lipids and
proteins of the membrane (Alouf, Jolivet-Reynaud, 1981).
Delta-toxin was purified from culture supernatant
by ammonium sulfate precipitation, thiol-Sepharose gel
chromatography, isoelectric focusing, and gel filtration
(Sephadex G-75). 200-fold purification was achieved by
using a four-step process descriptive above with recovery
of 16%. Some denaturation occurred during the isoelectric
focusing (Alouf, Jolivet-Reynaud, 1981). The purified
preparation showed a specific activity of 320,000
hemolytic units per mg of protein.
Lambda-toxin (λ)
The lambda-toxin is produced by most type B and E
strains and some type D strains of C. perfringens. It cau-
ses enteritis and enterotoxemia in domestic animals
(Madden, Horton, McCullough, 1970; Bidwell, 1950;
Hatheway, 1990). Studies indicated that this toxin is a zinc
metalloprotease with molecular weight 36 kDa (Jin et al.,
1996) and contributes to the pathogenicity by degrading
TABLE VI – Purification methods of toxins produced by Clostridium perfringens
Toxin  Procedure Purification  Advantages  Disadvantages
factor (-fold)
α Ultrafiltration with Millipore 305 Easy to perform, High cost
PSED OHV 10 and less laborious,
Amicon XM-100, gel filtration less time-consuming,
good purity
β Ammonium sulfate fractionation, 340 Good purity Long time-consuming,
Sephadex G-100, isoelectrofocusing not large-scale
in a pH 3 to 6 gradient, and purification
immunoaffinity chromatography
ε Ammonium sulfate precipitation, 77 Good purity -
chromatography DEAE-cellulose
θ Chromatography DEAE-Sephadex 3300 High purification Not tested for
A-50, and Sephadex G-150 factor, easy to perform large-scale purification
ι Ammonium sulfate precipitation, - - Long time-consuming,
chromatography DEAE-Sepharose laborious
CL-6B, isoelectric focusing,
chromatography Sephadex G-100
δ Ammonium sulfate precipitation, 200 Good purity Long time-consuming,
thiol-Sepharose gel chromatography, laborious
isoelectric focusing, Sephadex G-75
λ Ammonium sulfate precipitation, 87.7 Good purity Laborious
size exclusion, anion-exchange,
and hydrofobic interaction
chromatography
CPE Ammonium sulfate precipitation, 5.5 Easy to perform, Low purification factor
chromatography Sephacryl S-200 less laborious, less
time-consuming
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certain protein components of host cells. Alternatively, the
toxin may contribute to the pathogenesis by activating
other potent toxins, such as the epsilon- and iota-toxins,
produced by these type strains (Rood, Cole, 1991).
Lambda-toxin affects the vascular permeability, the same
mechanism of action shown by the epsilon-toxin (Jin et
al., 1996).
The lambda-toxin can be purified by ammonium
sulfate precipitation, followed by size exclusion, anion-
exchange, and hydrofobic interaction chromatography. By
using this sequence of purification the enrichment factor
and recovery yield of the lambda-toxin were estimated to
be 87-fold and 30.5%, respectively (Jin et al., 1996).
Enterotoxin (CPE)
C. perfringens produces an enterotoxin that is
responsible for human food poisoning in which diarrhea
and abdominal cramps are associated with the ingestion of
food contaminated. The enterotoxin is a single polypeptide
of 35 kDa that is produced and accumulated intracellularly
during sporulation of many strains of this microorganism,
and is released upon sporangial lysis (Labbe, 1989).
Due to the importance of this protein, several
methods have been developed to purify the enterotoxin
(Bartholomew, Stringer, 1983; McDonel, McClane, 1988;
Barnhart et al., 1976; Enders, Duncan, 1978; Granum,
Whitaker, 1980; Stark, Duncan, 1972; Uemura et al.,
1985). They include chromatography, such as affinity
chromatography, size exclusion molecular and high
performance liquid chromatography, polyacrylamide gel
electrophoresis. The most commonly employed
enterotoxin purification method involves a two-step
ammonium sulfate precipitation followed by gel filtration
on Sephadex G-100 (Granum, Whitaker, 1980).
The enterotoxin was also purified by using
ammonium sulfate precipitation followed by gel filtration
chromatography (Sephacryl S-200). The purification
factor was 5.5-fold, and the recovery yield was 50%. The
time (less than 48 h) and effort required by this
purification method are far less than any previously
reported procedure. Besides, the method may be useful for
those laboratories needing to produce significant amounts
of purified enterotoxin (Heredia, Garcia-Alvorado, Labbé,
1994).
CONCLUSIONS
Purification is troublesome because of system
complexity and the need to retain biological activity. The
purification procedures of different toxins produced by
Clostridium perfringens, and presented in this review,
involve multiple steps of the classical methodologies, such
as chromatography and precipitation with salts or organic
solvents. Comparing the results reported in the literature,
and presented in the tables of this paper, generally, the
purification factors were satisfactory for laboratory and
industrial scale, but the results, obviously, depend on the
type of toxin. The clear differences between purification
factors of the same or different toxins, is owing to the
characteristics of each individual protein. Besides, minor
changes in upstream processes may require changes in the
purification method to be applied. It is clearly observed
that the main objective of the downstream processing of
toxins is to attain high purification factors and recoveries,
at low cost. Therefore, depending on the target toxin, it is
necessary to include some adaptations of the current
purification methods.
RESUMO
Purificação de toxinas produzidas por Clostridium
perfringens: uma revisão
Clostridium perfringens é uma bactéria anaeróbia Gram-
positiva, amplamente distribuída no meio ambiente e
comumente encontrada no intestino de animais, incluin-
do o homem. As espécies de C. perfringens estão classifi-
cadas em cinco tipos toxigênicos (A, B, C, D, E) em fun-
ção da produção de quatro toxinas (α, β, ε, ι). Entretan-
to, as toxinas teta, delta, lambda e enterotoxina são tam-
bém sintetizadas por outras espécies dessa bactéria. Mui-
tas metodologias para purificação das toxinas produzidas
por C. perfringens têm sido propostas e, portanto, nesta
revisão foram apresentados e discutidos os métodos e re-
sultados de purificação dessas toxinas relatados nas últi-
mas quatro décadas.
UNITERMOS: Clostridium perfringens. Purificação. To-
xina. Processos.
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